RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-4873
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1346500; Gene model (P.falciparum): PF3D7_1331600; Gene product: protein tyrosine phosphatase-like protein, putative (PTPLA; 3-hydroxyacyl-CoA dehydratase; DEH)
Transgene
Transgene not Plasmodium: GFP (gfp-mut3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Oocyst; Sporozoite;
Last modified: 27 October 2020, 14:49
  *RMgm-4873
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 33106323
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherGuttery DS, Tewari R
Name Group/DepartmentSchool of Life Sciences, Queens Medical Centre
Name InstituteUniversity of Nottingham
CityNottingham
CountryUK
Name of the mutant parasite
RMgm numberRMgm-4873
Principal nameΔdeh
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystWhile the overall number of oocysts observed in Δdeh and WT lines was not significantly different, there was a significant reduction in Δdeh GFP-expressing oocysts beginning at day 7 and continuing through day 21 post-infection, with many appearing to be degenerating and were reduced in size compared to wild type oocysts.
Δdeh oocysts showed numerous cytoplasmic vacuoles with evidence of dilatation of the nuclear membranes.
SporozoiteNo salivary gland sporozoites
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of DEH and expresses GFP under control of the constitutive eef1a promoter

Protein (function)
In a genome-wide study of Plasmodium berghei (Pb) protein phosphatases,  30 phosphatase genes were identified together with one for a predicted protein tyrosine phosphatase-like protein, PbPTPLA, which was shown to be essential for sporozoite formation and completion of the parasite life cycle, but  not fully characterized (Guttery, Poulin et al., 2014).  However, despite the original annotation as an inactive PTP-like protein, more recent functional studies indicate that it is a key component of the VLCFA elongation cycle – more specifically the ELO pathway as a 3-hydroxyacyl-CoA dehydratase (DEH).
P. berghei (PBANKA_1346500) and P. falciparum (Pf; PF3D7_1331600) DEH genes are annotated as PTPLA (pfam04387), the criterion for PTPLA being the presence of a PTP active site motif (CXXGXXR) but with arginine replaced by proline (CXXGXXP). However, CLUSTALW alignment of Pb and Pf protein sequences with the human and mouse HACD1 and HACD2 shows this motif is absent, indicating that Plasmodium DEHs cannot be classified as PTP-like proteins. Furthermore, STRING database analysis predicts that PfDEH interacts with FAE and FAS proteins, and many other proteins with an ER location.

Phenotype
While the overall number of oocysts observed in Δdeh and WT lines was not significantly different, there was a significant reduction in Δdeh GFP-expressing oocysts beginning at day 7 and continuing through day 21 post-infection, with many appearing to be degenerating and were reduced in size compared to wild type oocysts. 
Δdeh oocysts showed numerous cytoplasmic vacuoles with evidence of dilatation of the nuclear membranes.

Additional information
See mutant RMgm-1087 which expresses a C-terminal GFP-tagged version of DEH and is used in this study.

From the paper: 'To determine the expression profile and location of PbDEH, we used a single homologous recombination strategy to tag the 3’ end of the endogenous deh locus with sequence coding for GFP (Guttery, Poulin et al., 2014), and then analyzed blood and mosquito stages of the life-cycle for GFP. Strong GFP fluorescence was observed throughout the life-cycle, with areas of localized expression in the cytoplasm and a circular ring formation around the nucleus. Predotar analysis predicted an ER localization for both PbDEH and PfDEH. Colocalization with ER tracker confirmed the DEH-GFP location at the ER, in all parasite stages analyzed, with subcellular fractionation of blood stage parasites confirming its integral membrane location'.


Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1346500
Gene Model P. falciparum ortholog PF3D7_1331600
Gene productprotein tyrosine phosphatase-like protein, putative
Gene product: Alternative namePTPLA; 3-hydroxyacyl-CoA dehydratase; DEH
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationDetails of GFP-tagged PTPLA (termed DEH-GFP in this study) and deh (PBANKA_1346500) knockout (KO) parasite lines (Δdeh in this study) are given in
(Guttery, Poulin et al., 2014). For this study, the KO construct was transfected into the GFPCON wild-type line (Janse, Franke-Fayard et al., 2006), with 3 clones produced by serial dilution.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mut3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4